Regulation of the human autologous T cell proliferation by endogenously generated C5a
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 127 (2) , 337-351
- https://doi.org/10.1016/0008-8749(90)90137-g
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Complement activation in patients with renal failure as detected through the quantitation of fragments of the complement proteins C3, C5, and factor BJournal of Molecular Medicine, 1988
- Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg.Journal of Clinical Investigation, 1988
- Identification of the C5a des Arg cochemotaxin. Homology with vitamin D-binding protein (group-specific component globulin).Journal of Clinical Investigation, 1988
- C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha.The Journal of Experimental Medicine, 1988
- Human monocyte spreading induced by activated factor B of the complement alternative pathway: Differential effects of Fab′ and F(ab′)2 antibody fragments directed to C5, C6, and C7Cellular Immunology, 1983
- Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages.The Journal of Experimental Medicine, 1982
- Biosynthesis of complement by human monocytesClinical Immunology and Immunopathology, 1981
- A potent mercapto bi-product analogue inhibitor for human carboxypeptidase NBiochemical and Biophysical Research Communications, 1981
- Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.The Journal of Experimental Medicine, 1980
- Enhancement of sheep red blood cell human lymphocyte rosette formation by the sulfhydryl compound 2-amino ethylisothiouronium bromideClinical Immunology and Immunopathology, 1975